Recently, the endogenous peptide ligand for an opioid-like g protein-coupled receptor (called LC 132 or ORL-10 has been identified and named orphanin FQ [OFQ] or nociceptin. The cDNA has been cloned and initial observations suggest that OFQ is contained in a larger precursor molecule as ae the enkephalins, endorphins and dynorphins. There appears to be several other putative peptides contained in the OFQ precursor, all bounded by paired-basic amino acids, a motif shared by many prohomones. We hypothesize that several other biologically active peptides are derived from the OFQ precursor and that the release of these peptides, including OFQ are regulated by dopamine and morphine. In order to test these hypotheses we will: 1) Determine the processing of prepro(PP)- OFQ-derived peptides in the rodent hypothalamus. These studies will characterize pp-OFQ-derived peptide liberated from the precusor and provide evidence that the peptides other than OFQ that are predicted from the cDNA are produced in hypothalamic neurons. 2) characterize the regulation of OFQ in monolayer cultures of hypothalamic neurons. Monolayer cultures of rat hypothalamic neurons will be incubated in the presence of ppiate receptor agonists or dopamine and the culture medium assayed for OFQ immunoreactivity. We will also continue to develop radioimmunoassays (RIAs) for each of the other neuropeptides potentially derived from pp-OfQ and use these assays to monitor the regulation of their secretion by dopamine and drugs of abuse. 3) Determien of glucocorticoids regulate pp-OFQ mRNA and peptide levels in vivo and ni vitro. We hypothesisze that OFQ-derived peptides are majormodulators of the stress response. We will use transgenic mie that have negligible circulating glucosteroids and subject them to acute and chronic restraint-stress. Hypothalamic OFQ peptide levlels will be measured by RIA and OFQ mRNA levels using molecular billogical methods. These studies will reveal whether OFQ levels are regulated by glucosteroids in the intact animal and thus potentially responsive to stress paradigms.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA011282-02
Application #
2733605
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Colvis, Christine
Project Start
1997-08-01
Project End
2000-06-30
Budget Start
1998-07-10
Budget End
1999-06-30
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Oregon Health and Science University
Department
Neurosciences
Type
Schools of Medicine
DUNS #
009584210
City
Portland
State
OR
Country
United States
Zip Code
97239
Washburn, C L; Bean, J E; Silverman, M A et al. (2002) Regulation of peptidergic vesicle mobility by secretagogues. Traffic 3:801-9
Rossi, Grace C; Pellegrino, Michael; Shane, Randi et al. (2002) Characterization of rat prepro-orphanin FQ/nociceptin((154-181)): nociceptive processing in supraspinal sites. J Pharmacol Exp Ther 300:257-64
Harrison, John M; Allen, Richard G; Pellegrino, Michael J et al. (2002) Chronic morphine treatment alters endogenous opioid control of hippocampal mossy fiber synaptic transmission. J Neurophysiol 87:2464-70
Mathis, J P; Rossi, G C; Pellegrino, M J et al. (2001) Carboxyl terminal peptides derived from prepro-orphanin FQ/nociceptin (ppOFQ/N) are produced in the hypothalamus and possess analgesic bioactivities. Brain Res 895:89-94
Allen, R G; Peng, B; Pellegrino, M J et al. (2001) Altered processing of pro-orphanin FQ/nociceptin and pro-opiomelanocortin-derived peptides in the brains of mice expressing defective prohormone convertase 2. J Neurosci 21:5864-70
Quigley, D I; Arttamangkul, S; Allen, R G et al. (2000) Integrity of tritiated orphanin FQ/nociceptin: implications for establishing a reliable binding assay. Peptides 21:1111-8
Sirianni, M J; Fujimoto, K I; Nelson, C S et al. (1999) Cyclic AMP analogs induce synthesis, processing, and secretion of prepro nociceptin/orphanin FQ-derived peptides by NS20Y neuroblastoma cells. DNA Cell Biol 18:51-8